共 50 条
- [11] CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy JCI INSIGHT, 2018, 3 (08):
- [20] CD40 and CD80/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1+ CD8+ T cells Cancer Immunology, Immunotherapy, 2022, 71 : 137 - 151